Findings

What do systematic reviews say?

2,447 questions · 2,590 findings · 266 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 699 · 27%GRADE not reported 289 · 11.2%Very low 614 · 23.7%Low 605 · 23.4%Moderate 322 · 12.4%High 61 · 2.4%

Breathing exercises vs inactive control

Days off work · adults with asthma

The review found no eligible studies for this question.

1 finding from 1 review

Breathing exercises for adults with asthma 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any pessary vs control, waiting list or no active treatment

Perceived resolution of prolapse symptoms ≥ 12 months · pelvic organ prolapse in women

The review found no eligible studies for this question.

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any pessary vs control, waiting list or no active treatment

Patients perceived improvement in symptoms of prolapse assessed using validated symptom questionnaire at 1 year ‐ not reported · pelvic organ prolapse in women

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Any pessary vs control, waiting list or no active treatment

Prolapse‐specific quality of life · pelvic organ prolapse in women

The review found no eligible studies for this question.

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any pessary vs control, waiting list or no active treatment

Improvement or cure of associated sexual symptoms · pelvic organ prolapse in women

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Any pessary vs control, waiting list or no active treatment

Psychological outcome measures at ≥ 12 months · pelvic organ prolapse in women

The review found no eligible studies for this question.

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any pessary vs control, waiting list or no active treatment

Number of women with adverse events (vaginal bleeding, voiding difficulty) · pelvic organ prolapse in women

The review found no eligible studies for this question.

1 finding from 1 review

Pessaries (mechanical devices) for managing pelvic organ prolapse in women 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs placebo

Clinical remission · people with active UC

Probiotics may leads to higher clinical remission compared with placebo (low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.73 [1.19, 2.54]
9 studies · 594 participants
Low

Probiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Disease improvement · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Remission · people with active UC

Probiotics plus 5‐aminosalicylic acid (5‐ASA) (mesalazine) may leads to higher remission compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.22 [1.01, 1.47]
1 study · 84 participants
Low

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Disease improvement · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Minor adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Serious adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Withdrawals due to adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs placebo

Disease improvement (based on clinical scores) · people with active UC

Probiotics may leads to higher disease improvement (based on clinical scores) compared with placebo (low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 2.29 [1.13, 4.63]
2 studies · 54 participants
Low

Probiotics vs placebo

Minor adverse events · people with active UC

It is very uncertain whether probiotics changes minor adverse events compared with placebo (very low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.04 [0.42, 2.59]
7 studies · 520 participants
Very low

Probiotics vs placebo

Serious adverse events · people with active UC

It is very uncertain whether probiotics changes serious adverse events compared with placebo (very low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 0.09 [0.01, 1.66]
7 studies · 526 participants
Very low

Probiotics vs placebo

Withdrawals due to adverse events · people with active UC

Probiotics showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 0.85 [0.42, 1.72]
4 studies · 401 participants
Low

Probiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Clinical remission · people with active UC

Probiotics showed no clear difference in clinical remission compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 0.92 [0.73, 1.16]
1 study · 116 participants
Low

Probiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Minor adverse events · people with active UC

It is very uncertain whether probiotics changes minor adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1
2 studies · 192 participants
Very low